U.S. Food and Drug Administration approves Gilead’s Sovaldi™ (sofosbuvir) for the treatment of chronic hepatitis C - MARG
December 6, 2013
U.S. Food and Drug Administration approves Gilead’s Sovaldi™ (sofosbuvir) for the treatment of chronic hepatitis C